{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:41:17Z","timestamp":1792597277397,"version":"4.5.0"},"reference-count":33,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2013,10]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>Although most meningiomas are benign, about 20% are atypical (Grade II or III) and have increased mortality and morbidity. Identifying tumors with greater malignant potential can have significant clinical value. This validated genome-wide methylation study comparing Grade I with Grade II and III meningiomas aims to discover genes that are aberrantly methylated in atypical meningiomas.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Patients with newly diagnosed meningioma were identified as part of the Ohio Brain Tumor Study. The Infinium HumanMethylation27 BeadChip (Illumina, Inc.) was used to interrogate 27,578 CpG sites in 14,000 genes per sample for a discovery set of 33 samples (3 atypical). To verify the results, the Infinium HumanMethylation450 BeadChip (Illumina, Inc.) was used to interrogate 450,000 cytosines at CpG loci throughout the genome for a verification set containing 7 replicates (3 atypical), as well as 12 independent samples (6 atypical). A nonparametric Wilcoxon exact test was used to test for difference in methylation between benign and atypical meningiomas in both sets. Heat maps were generated for each set. Methylation results were validated for the 2 probes with the largest difference in methylation intensity by performing Western blot analysis on a set of 20 (10 atypical) samples, including 11 replicates.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The discovery array identified 95 probes with differential methylation between benign and atypical meningiomas, creating 2 distinguishable groups corresponding to tumor grade when visually examined on a heat map. The validation array evaluated 87 different probes and showed that 9 probes were differentially methylated. On heat map examination the results of this array also suggested the existence of 2 major groups that corresponded to histological grade. IGF2BP1 and PDCD1, 2 proteins that can increase the malignant potential of tumors, were the 2 probes with the largest difference in intensity, and for both of these the atypical meningiomas had a decreased median production of protein, though this was not statistically significant (p = 0.970 for IGF2BP1 and p = 1 for PDCD1).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>A genome-wide methylation analysis of benign and atypical meningiomas identified 9 genes that were reliably differentially methylated, with the strongest difference in IGF2BP1 and PDCD1. The mechanism why increased methylation of these sites is associated with an aggressive phenotype is not evident. Future research may investigate this mechanism, as well as the utility of IGF2BP1 as a marker for pathogenicity in otherwise benign-appearing meningiomas.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2013.7.jns13311","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T14:01:55Z","timestamp":1376056915000},"page":"899-906","source":"Crossref","is-referenced-by-count":25,"title":["Methylation markers of malignant potential in meningiomas"],"prefix":"10.3171","volume":"119","author":[{"given":"Jaime","family":"Vengoechea","sequence":"first","affiliation":[{"name":"Division of Genetics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Sloan","sequence":"additional","affiliation":[{"name":"Brain Tumor and Neuro-oncology Center, Department of Neurosurgery, University Hospitals Case Medical Center, Case Western Reserve School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanwen","family":"Chen","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Guan","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinn T.","family":"Ostrom","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Kerstetter","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Center for Translational Neuroscience, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devan","family":"Capella","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Center for Translational Neuroscience, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingli","family":"Wolinsky","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Devine","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Selman","sequence":"additional","affiliation":[{"name":"Brain Tumor and Neuro-oncology Center, Department of Neurosurgery, University Hospitals Case Medical Center, Case Western Reserve School of Medicine;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene H.","family":"Barnett","sequence":"additional","affiliation":[{"name":"Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Department of Neurosurgery, Neurological and Taussig Cancer Institute, Cleveland Clinic, Cleveland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald E.","family":"Warnick","sequence":"additional","affiliation":[{"name":"Brain Tumor Center at the University of Cincinnati Neuroscience Institute, and Department of Neurosurgery, University of Cincinnati College of Medicine, and Mayfield Clinic, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McPherson","sequence":"additional","affiliation":[{"name":"Brain Tumor Center at the University of Cincinnati Neuroscience Institute, and Department of Neurosurgery, University of Cincinnati College of Medicine, and Mayfield Clinic, Cincinnati, Ohio;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Antonio","family":"Chiocca","sequence":"additional","affiliation":[{"name":"Institute for the Neurosciences, Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Bradley","family":"Elder","sequence":"additional","affiliation":[{"name":"Dardinger Neuro-Oncology Center, Department of Neurosurgery, James Comprehensive Cancer Center and The Ohio State University Medical Center, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill S.","family":"Barnholtz-Sloan","sequence":"additional","affiliation":[{"name":"Case Comprehensive Cancer Center,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns13311","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3171\/jns.2004.101.2.0210","article-title":"Malignant progression in meningioma: documentation of a series and analysis of cytogenetic findings","volume":"101","author":"Al-Mefty","year":"2004"},{"key":"b2-jns13311","series-title":"Genet Test Mol Biomarkers","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/gtmb.2011.0245","article-title":"Identification of promoter region methylation patterns of MGMT, CDKN2A, GSTP1, and THBS1 genes in intracranial meningioma patients","volume":"16","author":"Aydemir","year":"2012"},{"key":"b3-jns13311","series-title":"Brain Pathol","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/j.1750-3639.2009.00340.x","article-title":"Hypermethylation and transcriptional downregulation of the TIMP3 gene is associated with allelic loss on 22q12.3 and malignancy in meningiomas","volume":"20","author":"Barski","year":"2010"},{"key":"b4-jns13311","series-title":"Genome Res","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1101\/gr.4410706","article-title":"High-throughput DNA methylation profiling using universal bead arrays","volume":"16","author":"Bibikova","year":"2006"},{"key":"b5-jns13311","series-title":"Cancer Immunol Immunother","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00262-004-0593-x","article-title":"Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy","volume":"54","author":"Blank","year":"2005"},{"key":"b6-jns13311","series-title":"Nat Rev Genet","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrg3273","article-title":"Analysing and interpreting DNA methylation data","volume":"13","author":"Bock","year":"2012"},{"issue":"Suppl 5","key":"b7-jns13311","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009","volume":"14","author":"Dolecek","year":"2012"},{"key":"b8-jns13311","series-title":"Neurologist","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/01.nrl.0000126588.14216.f3","article-title":"Meningiomas: updating basic science, management, and outcome","volume":"10","author":"Drummond","year":"2004"},{"key":"b9-jns13311","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11060-009-9934-0","article-title":"WHO grade II and III meningiomas: a study of prognostic factors","volume":"95","author":"Durand","year":"2009"},{"key":"b10-jns13311","series-title":"Hepatology","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/hep.22649","article-title":"Blocking the hedgehog pathway inhibits hepatoblastoma growth","volume":"49","author":"Eichenm\u00fcller","year":"2009"},{"key":"b11-jns13311","series-title":"Oncogene","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1038\/onc.2010.37","article-title":"Centrobin regulates the assembly of functional mitotic spindles","volume":"29","author":"Jeffery","year":"2010"},{"key":"b12-jns13311","series-title":"Mutat Res","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mrfmmm.2003.08.010","article-title":"Checkpoint responses to replication stalling: inducing tolerance and preventing mutagenesis","volume":"532","author":"Kai","year":"2003"},{"key":"b13-jns13311","series-title":"Carcinogenesis","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/carcin\/bgr260","article-title":"Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses","volume":"33","author":"Kishida","year":"2012"},{"key":"b14-jns13311","series-title":"Curr Opin Investig Drugs","first-page":"1354","article-title":"Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer","volume":"11","author":"Kline","year":"2010"},{"key":"b15-jns13311","series-title":"Nat Rev Genet","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrg2732","article-title":"Principles and challenges of genomewide DNA methylation analysis","volume":"11","author":"Laird","year":"2010"},{"key":"b16-jns13311","series-title":"Mol Cell Biol","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1128\/MCB.22.12.3959-3969.2002","article-title":"Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant","volume":"22","author":"Lemm","year":"2002"},{"key":"b17-jns13311","series-title":"Hum Pathol","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.humpath.2005.02.006","article-title":"Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas","volume":"36","author":"Liu","year":"2005"},{"key":"b18-jns13311","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-05-0043","article-title":"Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma","volume":"65","author":"Lusis","year":"2005"},{"key":"b19-jns13311","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","article-title":"Pathological classification and molecular genetics of meningiomas","volume":"99","author":"Mawrin","year":"2010"},{"key":"b20-jns13311","series-title":"Nucleic Acids Res","first-page":"D64","article-title":"The UCSC Genome Browser database: extensions and updates 2013","volume":"41","author":"Meyer","year":"2013"},{"key":"b21-jns13311","series-title":"Gene","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.gene.2012.07.059","article-title":"Programmed death-1 gene polymorphism (PD-1.5 C\/T) is associated with colon cancer","volume":"508","author":"Mojtahedi","year":"2012"},{"key":"b22-jns13311","series-title":"Brain Pathol","first-page":"183","article-title":"A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas","volume":"12","author":"Perry","year":"2002"},{"key":"b23-jns13311","series-title":"Am J Surg Pathol","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1097\/00000478-199712000-00008","article-title":"Meningioma grading: an analysis of histologic parameters","volume":"21","author":"Perry","year":"1997"},{"key":"b24-jns13311","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s11060-010-0401-8","article-title":"Human hedgehog interacting protein expression and promoter methylation in medulloblastoma cell lines and primary tumor samples","volume":"103","author":"Shahi","year":"2011"},{"key":"b25-jns13311","series-title":"Int J Oncol","first-page":"97","article-title":"Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma","volume":"30","author":"Shimada","year":"2007"},{"key":"b26-jns13311","series-title":"Steroids","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.steroids.2008.05.003","article-title":"Heterologous expression of human mPRalpha, mPRbeta and mPRgamma in yeast confirms their ability to function as membrane progesterone receptors","volume":"73","author":"Smith","year":"2008"},{"key":"b27-jns13311","series-title":"Genes Dev","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1101\/gad.177642.111","article-title":"IGF2BP1 promotes cell migration by regulating MK5 and PTEN signaling","volume":"26","author":"St\u00f6hr","year":"2012"},{"key":"b28-jns13311","series-title":"Carcinogenesis","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1093\/carcin\/bgp114","article-title":"Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers","volume":"30","author":"Tessema","year":"2009"},{"key":"b29-jns13311","series-title":"Int Immunol","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/intimm\/dxp072","article-title":"PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells","volume":"21","author":"Wang","year":"2009"},{"key":"b30-jns13311","series-title":"RNA","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1261\/rna.1175909","article-title":"Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs","volume":"15","author":"Weidensdorfer","year":"2009"},{"key":"b31-jns13311","series-title":"Blood","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.1182\/blood-2003-04-1150","article-title":"Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib","volume":"102","author":"Wilkinson","year":"2003"},{"key":"b32-jns13311","series-title":"Cancer Res","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1158\/0008-5472.CAN-11-1620","article-title":"Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape","volume":"72","author":"Woo","year":"2012"},{"key":"b33-jns13311","series-title":"Biol Cell","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1042\/BC20040151","article-title":"VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins","volume":"97","author":"Yisraeli","year":"2005"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/119\/4\/article-p899.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/119\/4\/article-p899.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/119\/4\/article-p899.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T17:22:27Z","timestamp":1660497747000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/119\/4\/article-p899.xml"}},"subtitle":["Laboratory investigation"],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":33,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2013.7.jns13311","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10]]}}}